Advanced

Effects of Pay-For-Performance on Prescription of Hypertension Drugs among Public and Private Primary Care Providers in Sweden

Ellegård, Lina Maria LU (2018) In Working Papers
Abstract
This study exploits policy reforms in Swedish primary care to examine the effect of pay-for-performance (P4P) on compliance with hypertension drug guidelines among public and private health care providers. Providers in regions with P4P are compared to providers in other regions in a difference-in-differences analysis using data from the Swedish Prescription Register for the period 2005-2013. The results indicate that P4P improved guideline compliance regarding prescription of Angiotensin Converting Enzyme (ACE) inhibitors and Angiotensin Receptor Blockers (ARB). The effect is mainly driven by private providers, suggesting that policy makers should take ownership into account when designing incentives for health care providers.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Working Paper
publication status
published
subject
keywords
Pay-for-performance, Hypertension treatment, Ownership, Primary health care, D23, H73, I11, I18, J33
in
Working Papers
issue
2018:6
pages
25 pages
language
English
LU publication?
yes
id
0c22d60a-19fd-424d-bc6f-d7d27919b57c
alternative location
https://swopec.hhs.se/lunewp/abs/lunewp2018_006.htm
date added to LUP
2018-03-28 09:33:47
date last changed
2018-11-21 21:38:56
@misc{0c22d60a-19fd-424d-bc6f-d7d27919b57c,
  abstract     = {This study exploits policy reforms in Swedish primary care to examine the effect of pay-for-performance (P4P) on compliance with hypertension drug guidelines among public and private health care providers. Providers in regions with P4P are compared to providers in other regions in a difference-in-differences analysis using data from the Swedish Prescription Register for the period 2005-2013. The results indicate that P4P improved guideline compliance regarding prescription of Angiotensin Converting Enzyme (ACE) inhibitors and Angiotensin Receptor Blockers (ARB). The effect is mainly driven by private providers, suggesting that policy makers should take ownership into account when designing incentives for health care providers. },
  author       = {Ellegård, Lina Maria},
  keyword      = {Pay-for-performance,Hypertension treatment,Ownership,Primary health care, D23,H73,I11, I18,J33 },
  language     = {eng},
  note         = {Working Paper},
  number       = {2018:6},
  pages        = {25},
  series       = {Working Papers},
  title        = {Effects of Pay-For-Performance on Prescription of Hypertension Drugs among Public and Private Primary Care Providers in Sweden},
  year         = {2018},
}